Novel PKD1 mutations – the effect on clinical phenotype of ADPKD patients in Lower Silesia

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development and progressive enlargement of cysts in the kidneys. The diagnosis of ADPKD is usually determined by criteria of renal ultrasound imaging of the development and number of cysts. However, in atypical cystic disease, for the recognition of ADPKD, DNA-based assays may be required.Materials and methods: In the present study PCR amplified fragments of the PKD1 gene (covering exons 15 and 43- 44) from genomic DNA of 134 Lower Silesia patients were analyzed for mutations and polymorphisms. Among them, the clinical significance of different PKD1 mutations was investigated in 81 persons.Results: Eight new, previously undescribed, and 2 recurrent mutations were discovered. The presence of 3 known polymorphisms was confirmed. Seven of the 8 new discovered mutations were heterozygous.Discussion: The results of the present study demonstrated that the frequency of genetic abnormalities in the analyzed fragments of the PKD1 gene in the Lower Silesian population is smaller than previously reported. Moreover, we could not detect deletions and insertions, which are often present is these regions of the PKD1 gene, which may be due to the limited number of screened patients. We conclude that none of the discovered changes in the PKD1 gene had any effect on clinical phenotype of the disease.

Authors and Affiliations

Hanna Augustyniak-Bartosik, Magdalena Krajewska, Wacław Weyde, Katarzyna Madziarska, Michał Rurek, Marian Klinger

Keywords

Related Articles

The discovery of neuromedin U and its pivotal role in the central regulation of energy homeostasis

Neuromedin U (NMU) is a structurally highly conserved neuropeptide and has been paired with the G-protein-coupled receptors (GPCRs) NMUR1 and NMUR2, which were formerly classified in the orphan receptor family. Activati...

Metabolizm endokannabinoidów

Endokannabinoidy należą do grupy estrowych, eterowych oraz amidowych pochodnych kwasów tłuszczowych, będących endogennymi ligandami receptorów CB1, CB2, TRPV1 i GPR55, wchodzącymi w skład endokannabinoidowego systemu org...

Perspektywy wykorzystania interferencji RNA w terapii chorób związanych z zaburzeniami alternatywnego składania RNA

Pierwotny transkrypt genu eukariotycznego (pre-mRNA) składa się z regionów kodujących – eksonów, poprzedzielanych sekwencjami niekodującymi intronami, które usuwane są w procesie składania RNA, co prowadzi do powstania d...

Download PDF file
  • EP ID EP66876
  • DOI -
  • Views 153
  • Downloads 0

How To Cite

Hanna Augustyniak-Bartosik, Magdalena Krajewska, Wacław Weyde, Katarzyna Madziarska, Michał Rurek, Marian Klinger (2013). Novel PKD1 mutations – the effect on clinical phenotype of ADPKD patients in Lower Silesia. Advances in Hygiene and Experimental Medicine, 67(0), 157-163. https://europub.co.uk/articles/-A-66876